Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) shares dropped 1.9% during mid-day trading on Friday . The company traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.33). Approximately 49,264 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).
Mereo BioPharma Group plc (MPH.L) Stock Performance
The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The company has a market capitalization of £89.76 million and a PE ratio of -0.21. The company has a 50 day moving average price of GBX 26.50 and a 200 day moving average price of GBX 26.50.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Articles
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Stock Dividend Cuts Happen Are You Ready?
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
